Comprehensive Methodology for Sample Augmentation in EEG Biomarker Studies for Alzheimers Risk Classification
Authors:
Veronica Henao Isaza,
David Aguillon,
Carlos Andres Tobon Quintero,
Francisco Lopera,
John Fredy Ochoa Gomez
Abstract:
Background: Dementia, marked by cognitive decline, is a global health challenge. Alzheimer's disease (AD), the leading type, accounts for ~70% of cases. Electroencephalography (EEG) measures show promise in identifying AD risk, but obtaining large samples for reliable comparisons is challenging. Objective: This study integrates signal processing, harmonization, and statistical techniques to enhanc…
▽ More
Background: Dementia, marked by cognitive decline, is a global health challenge. Alzheimer's disease (AD), the leading type, accounts for ~70% of cases. Electroencephalography (EEG) measures show promise in identifying AD risk, but obtaining large samples for reliable comparisons is challenging. Objective: This study integrates signal processing, harmonization, and statistical techniques to enhance sample size and improve AD risk classification reliability. Methods: We used advanced EEG preprocessing, feature extraction, harmonization, and propensity score matching (PSM) to balance healthy non-carriers (HC) and asymptomatic E280A mutation carriers (ACr). Data from four databases were harmonized to adjust site effects while preserving covariates like age and sex. PSM ratios (2:1, 5:1, 10:1) were applied to assess sample size impact on model performance. The final dataset underwent machine learning analysis with decision trees and cross-validation for robust results. Results: Balancing sample sizes via PSM significantly improved classification accuracy, ranging from 0.92 to 0.96 across ratios. This approach enabled precise risk identification even with limited samples. Conclusion: Integrating data processing, harmonization, and balancing techniques improves AD risk classification accuracy, offering potential for other neurodegenerative diseases.
△ Less
Submitted 20 November, 2024;
originally announced November 2024.
Analysis and Evaluation of Handwriting in Patients with Parkinson's Disease Using kinematic, Geometrical, and Non-linear Features
Authors:
C. D. Rios-Urrego,
J. C. Vásquez-Correa,
J. F. Vargas-Bonilla,
E. Nöth,
F. Lopera,
J. R. Orozco-Arroyave
Abstract:
Background and objectives: Parkinson's disease is a neurological disorder that affects the motor system producing lack of coordination, resting tremor, and rigidity. Impairments in handwriting are among the main symptoms of the disease. Handwriting analysis can help in supporting the diagnosis and in monitoring the progress of the disease. This paper aims to evaluate the importance of different gr…
▽ More
Background and objectives: Parkinson's disease is a neurological disorder that affects the motor system producing lack of coordination, resting tremor, and rigidity. Impairments in handwriting are among the main symptoms of the disease. Handwriting analysis can help in supporting the diagnosis and in monitoring the progress of the disease. This paper aims to evaluate the importance of different groups of features to model handwriting deficits that appear due to Parkinson's disease; and how those features are able to discriminate between Parkinson's disease patients and healthy subjects.
Methods: Features based on kinematic, geometrical and non-linear dynamics analyses were evaluated to classify Parkinson's disease and healthy subjects. Classifiers based on K-nearest neighbors, support vector machines, and random forest were considered.
Results: Accuracies of up to $93.1\%$ were obtained in the classification of patients and healthy control subjects. A relevance analysis of the features indicated that those related to speed, acceleration, and pressure are the most discriminant. The automatic classification of patients in different stages of the disease shows $κ$ indexes between $0.36$ and $0.44$. Accuracies of up to $83.3\%$ were obtained in a different dataset used only for validation purposes.
Conclusions: The results confirmed the negative impact of aging in the classification process when we considered different groups of healthy subjects. In addition, the results reported with the separate validation set comprise a step towards the development of automated tools to support the diagnosis process in clinical practice.
△ Less
Submitted 13 February, 2020;
originally announced February 2020.
